Search research articles
Contact Us
Filters
Showing results (111-120 of 133) with videos related to
Page
of 14
Sort By:
JCO Precision Oncology
|
January 5, 2023
<i>HRAS</i> Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma
Niamh Coleman, Kathrina L Marcelo, Julia F Hopkins, et al.
The Journal of the Kentucky Medical Association
|
March 28, 2001
Stereotactic breast biopsy: a six-year surgical experience
P S Tate, E L Rogers, E M McGee, et al.
Analytical Chemistry
|
November 30, 2007
Fully automated four-column capillary LC-MS system for maximizing throughput in proteomic analyses
Eric A Livesay, Keqi Tang, Beverley K Taylor, et al.
Applied Physics Letters
|
November 13, 2024
AC metrology applications of the Josephson effect
S P Benz, J Biesecker, C J Burroughs, et al.
Monthly Notices of the Royal Astronomical Society
|
January 2, 2019
The origin of the diverse morphologies and kinematics of Milky Way-mass galaxies in the FIRE-2 simulations
Shea Garrison-Kimmel, Philip F Hopkins, Andrew Wetzel, et al.
JCO Precision Oncology
|
June 15, 2022
Molecular Characterization of Mesothelioma: Impact of Histologic Type and Site of Origin on Molecular Landscape
Ibiayi Dagogo-Jack, Russell W Madison, Jochen K Lennerz, et al.
Journal of Proteome Research
|
December 17, 2009
An LC-IMS-MS platform providing increased dynamic range for high-throughput proteomic studies
Erin Shammel Baker, Eric A Livesay, Daniel J Orton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 10, 2006
Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling
Masaya Baba, Seung-Beom Hong, Nirmala Sharma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2022
Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast Cancer
Joanne L Blum, A Douglas Laird, Jennifer K Litton, et al.
Breast Cancer (Tokyo, Japan)
|
June 13, 2024
Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status
Melinda L Telli, Jennifer K Litton, J Thaddeus Beck, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 133) with videos related to
Sort By:
Page
of 14
JCO Precision Oncology
|
January 5, 2023
<i>HRAS</i> Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma
Niamh Coleman, Kathrina L Marcelo, Julia F Hopkins, et al.
The Journal of the Kentucky Medical Association
|
March 28, 2001
Stereotactic breast biopsy: a six-year surgical experience
P S Tate, E L Rogers, E M McGee, et al.
Analytical Chemistry
|
November 30, 2007
Fully automated four-column capillary LC-MS system for maximizing throughput in proteomic analyses
Eric A Livesay, Keqi Tang, Beverley K Taylor, et al.
Applied Physics Letters
|
November 13, 2024
AC metrology applications of the Josephson effect
S P Benz, J Biesecker, C J Burroughs, et al.
Monthly Notices of the Royal Astronomical Society
|
January 2, 2019
The origin of the diverse morphologies and kinematics of Milky Way-mass galaxies in the FIRE-2 simulations
Shea Garrison-Kimmel, Philip F Hopkins, Andrew Wetzel, et al.
JCO Precision Oncology
|
June 15, 2022
Molecular Characterization of Mesothelioma: Impact of Histologic Type and Site of Origin on Molecular Landscape
Ibiayi Dagogo-Jack, Russell W Madison, Jochen K Lennerz, et al.
Journal of Proteome Research
|
December 17, 2009
An LC-IMS-MS platform providing increased dynamic range for high-throughput proteomic studies
Erin Shammel Baker, Eric A Livesay, Daniel J Orton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 10, 2006
Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling
Masaya Baba, Seung-Beom Hong, Nirmala Sharma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2022
Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast Cancer
Joanne L Blum, A Douglas Laird, Jennifer K Litton, et al.
Breast Cancer (Tokyo, Japan)
|
June 13, 2024
Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status
Melinda L Telli, Jennifer K Litton, J Thaddeus Beck, et al.
Page
of 14